The F. Dohmen Co. · Milwaukee, WI United States
Company Description
View The F. Dohmen Co. Locations On A US Map
This link will open in a new window
This link will open in a new window The F. Dohmen Co. no longer has to decipher doctor's scribbles, but it still works to get prescriptions filled. Its RESTAT subsidiary is a prescription benefits management company, handling the drug benefit plans of some 6 million covered members through a network of more than 62,000 pharmacies. RESTAT helps insurers, third-party administrators, self-insured employers and others with claims services, and clinical management, among other things. The company's DDN subsidiary provides pharmaceutical logistics services to smaller drug companies. Its services include new product launching, regulatory compliance, and specialty pharmaceutical handling --including DEA certification to handle controlled substances. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key The F. Dohmen Co. Financials
| Company Type | Private Headquarters |
| Fiscal Year-End | April |
| Employees | 300 |
The F. Dohmen Co. Executives
15 executives listed for The F. Dohmen Co.'s Milwaukee, WI location.
| Title | Name & Bio | Contact |
| Chairman | John Dohmen | Network |
| CEO | Cynthia LaConte | Network |
| Chief Performance Officer | Bill von Rohr | Network |
Competition
Competitive Landscape for The F. Dohmen Co.
Demand for health insurance products is driven by the rising costs of medical care. The profitability of individual companies depends on efficient operations and the ability to negotiate favorable contracts with healthcare providers. Large companies and organizations have advantages in negotiating contracts with healthcare providers. Small companies can compete successfully by providing special coverage plans as part of government programs such as Medicaid, or for specialized populations. The industry is highly automated and capital-intensive: annual revenue per employee is close to $1 million. Reforming the US healthcare industry continues to be a top agenda item in Washington, but a consensus on the best way to reduce healthcare spending has yet to be reached. The managed healthcare industry will most certainly be impacted by any changes initiated by federal legislators. To read the full description, subscribe now.Top The F. Dohmen Co. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!